FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4280497904> ?p ?o ?g. }

• W4280497904 abstract "Introduction: Shoulder arthroscopy can result in substantial postoperative pain. Sucrose acetate isobutyrate extended-release bupivacaine (SABER-Bupivacaine; trade name Posimir) is a novel depot formulation of bupivacaine designed to provide analgesia at the surgical site for up to 72 hours. The objective of this study was to evaluate the effect of SABER-Bupivacaine on pain and opioid consumption after arthroscopic subacromial decompression and to assess short-term and long-term safety. Methods: In this double-blind, placebo-controlled trial, 78 subjects were randomized in a 2:1 ratio to SABER-Bupivacaine 5 mL or SABER-placebo 5 mL injected into the subacromial space just before skin closure. Twenty-nine additional subjects were randomized on an exploratory basis to bupivacaine hydrochloride 20 mL, also injected subacromially. Subjects rated pain intensity on a 0 to 10 scale over the first 3 postoperative days and received intravenous or oral morphine for breakthrough pain. The coprimary efficacy end points were pain intensity on 90° shoulder flexion and cumulative morphine intake from 0 to 72 hours after surgery. The time to first use of opioid rescue analgesia was a secondary end point. Results: The mean (SD) pain intensity was 5.16 (1.94) for SABER-Bupivacaine and 6.43 (1.77) for placebo (P = 0.012). The median consumption of intravenous morphine equivalents was 4.0 mg for SABER-Bupivacaine and 12.0 mg for placebo (P = 0.010). The median time to first use of morphine rescue was 12.4 hours for SABER-Bupivacaine and 1.2 hours for placebo (P = 0.014). The corresponding values for bupivacaine hydrochloride were 5.16 (2.38), 8.0 mg, and 1.4 hours. The incidence and severity of treatment-emergent adverse events were similar for all treatment groups, and no functional or radiographic differences were noted at the 6-month follow-up. Discussion: Compared with placebo, SABER-Bupivacaine reduced pain and opioid analgesic consumption over 72 hours after arthroscopic subacromial decompression and prolonged the time to first use of opioid rescue analgesia. No safety signals were noted during the immediate postoperative period or at 6-month follow-up." @default.
• W4280497904 created "2022-05-22" @default.
• W4280497904 creator A5000866627 @default.
• W4280497904 creator A5002736166 @default.
• W4280497904 creator A5063383034 @default.
• W4280497904 creator A5078692375 @default.
• W4280497904 creator A5080831509 @default.
• W4280497904 creator A5084428403 @default.
• W4280497904 date "2022-05-01" @default.
• W4280497904 modified "2023-10-14" @default.
• W4280497904 title "SABER-Bupivacaine Reduces Postoperative Pain and Opioid Consumption After Arthroscopic Subacromial Decompression: A Randomized, Placebo-Controlled Trial" @default.
• W4280497904 cites W1549559083 @default.
• W4280497904 cites W1699827145 @default.
• W4280497904 cites W1896208131 @default.
• W4280497904 cites W1908515681 @default.
• W4280497904 cites W1985324768 @default.
• W4280497904 cites W1987233183 @default.
• W4280497904 cites W1991824299 @default.
• W4280497904 cites W1996865887 @default.
• W4280497904 cites W2005886529 @default.
• W4280497904 cites W2006194553 @default.
• W4280497904 cites W2018978943 @default.
• W4280497904 cites W2034950456 @default.
• W4280497904 cites W2037405274 @default.
• W4280497904 cites W2042716089 @default.
• W4280497904 cites W2043177715 @default.
• W4280497904 cites W2053947031 @default.
• W4280497904 cites W2059012210 @default.
• W4280497904 cites W2081695825 @default.
• W4280497904 cites W2084144406 @default.
• W4280497904 cites W2098960917 @default.
• W4280497904 cites W2130141996 @default.
• W4280497904 cites W2132309748 @default.
• W4280497904 cites W2138261897 @default.
• W4280497904 cites W2139624088 @default.
• W4280497904 cites W2139917444 @default.
• W4280497904 cites W2163189493 @default.
• W4280497904 cites W2259797591 @default.
• W4280497904 cites W2324378677 @default.
• W4280497904 cites W2460066114 @default.
• W4280497904 cites W2607168684 @default.
• W4280497904 cites W2913049709 @default.
• W4280497904 cites W930965824 @default.
• W4280497904 doi "https://doi.org/10.5435/jaaosglobal-d-21-00287" @default.
• W4280497904 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35584248" @default.
• W4280497904 hasPublicationYear "2022" @default.
• W4280497904 type Work @default.
• W4280497904 citedByCount "1" @default.
• W4280497904 countsByYear W42804979042023 @default.
• W4280497904 crossrefType "journal-article" @default.
• W4280497904 hasAuthorship W4280497904A5000866627 @default.
• W4280497904 hasAuthorship W4280497904A5002736166 @default.
• W4280497904 hasAuthorship W4280497904A5063383034 @default.
• W4280497904 hasAuthorship W4280497904A5078692375 @default.
• W4280497904 hasAuthorship W4280497904A5080831509 @default.
• W4280497904 hasAuthorship W4280497904A5084428403 @default.
• W4280497904 hasBestOaLocation W42804979041 @default.
• W4280497904 hasConcept C126322002 @default.
• W4280497904 hasConcept C141071460 @default.
• W4280497904 hasConcept C142724271 @default.
• W4280497904 hasConcept C168563851 @default.
• W4280497904 hasConcept C170493617 @default.
• W4280497904 hasConcept C204787440 @default.
• W4280497904 hasConcept C27081682 @default.
• W4280497904 hasConcept C2777389121 @default.
• W4280497904 hasConcept C2779480328 @default.
• W4280497904 hasConcept C2780820201 @default.
• W4280497904 hasConcept C2781063702 @default.
• W4280497904 hasConcept C2781328992 @default.
• W4280497904 hasConcept C42219234 @default.
• W4280497904 hasConcept C71924100 @default.
• W4280497904 hasConceptScore W4280497904C126322002 @default.
• W4280497904 hasConceptScore W4280497904C141071460 @default.
• W4280497904 hasConceptScore W4280497904C142724271 @default.
• W4280497904 hasConceptScore W4280497904C168563851 @default.
• W4280497904 hasConceptScore W4280497904C170493617 @default.
• W4280497904 hasConceptScore W4280497904C204787440 @default.
• W4280497904 hasConceptScore W4280497904C27081682 @default.
• W4280497904 hasConceptScore W4280497904C2777389121 @default.
• W4280497904 hasConceptScore W4280497904C2779480328 @default.
• W4280497904 hasConceptScore W4280497904C2780820201 @default.
• W4280497904 hasConceptScore W4280497904C2781063702 @default.
• W4280497904 hasConceptScore W4280497904C2781328992 @default.
• W4280497904 hasConceptScore W4280497904C42219234 @default.
• W4280497904 hasConceptScore W4280497904C71924100 @default.
• W4280497904 hasIssue "5" @default.
• W4280497904 hasLocation W42804979041 @default.
• W4280497904 hasLocation W42804979042 @default.
• W4280497904 hasLocation W42804979043 @default.
• W4280497904 hasLocation W42804979044 @default.
• W4280497904 hasLocation W42804979045 @default.
• W4280497904 hasOpenAccess W4280497904 @default.
• W4280497904 hasPrimaryLocation W42804979041 @default.
• W4280497904 hasRelatedWork W1984168887 @default.
• W4280497904 hasRelatedWork W2025058623 @default.
• W4280497904 hasRelatedWork W2030413770 @default.
• W4280497904 hasRelatedWork W2062112351 @default.
• W4280497904 hasRelatedWork W2113880444 @default.
• W4280497904 hasRelatedWork W2120947904 @default.
• W4280497904 hasRelatedWork W2130726670 @default.

• next